Anders Fuglsang
One Year On: The Bioequivalence Guidelines
July 20 by Helen WinsorHelmut Schuetz of BEBAC Consultancy and Anders Fuglsang of Fuglsang Pharma Consultancy, join Pharma IQ to discuss the impact of the bioequivalence guidelines introduced in summer 2010 on the pharmac...
Guidelines are Not Recipes: Biowaivers and Beyond
April 25 by Anders FuglsangAhead of the 2nd Annual Bioequivalence and Bioavailability Studies conference, Pharma IQ caught up with Anders Fuglsang from FuglsangPharma. Fuglsang is a former EU regulator (clinical asses...